Kineta, Inc. (KA)
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
$8.08M
Dr. Shawn P. Iadonato Ph.D.
11.00
Seattle, WA
Feb 11, 2016
-0.40
$-1.64
0.22
0.25
-2,173.27%
-0.45
-0.02
-1.27
10.57
0.22
-735.14%
-1,066.87%
Similar stocks (16)
XOMA Corporation
XOMAO
PepGen Inc.
PEPG
Rezolute, Inc.
RZLT
Candel Therapeutics, Inc.
CADL
DiaMedica Therapeutics Inc.
DMAC
AlloVir, Inc.
ALVR
Anebulo Pharmaceuticals, Inc.
ANEB
Dyadic International, Inc.
DYAI
Tempest Therapeutics, Inc.
TPST
MiNK Therapeutics, Inc.
INKT
Lumos Pharma, Inc.
LUMO
AN2 Therapeutics, Inc.
ANTX
Forte Biosciences, Inc.
FBRX
Kintara Therapeutics, Inc.
KTRA
Silo Pharma, Inc.
SILO
Protagenic Therapeutics, Inc.
PTIX
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (16)
XOMA Corporation
XOMAO
PepGen Inc.
PEPG
Rezolute, Inc.
RZLT
Candel Therapeutics, Inc.
CADL
DiaMedica Therapeutics Inc.
DMAC
AlloVir, Inc.
ALVR
Anebulo Pharmaceuticals, Inc.
ANEB
Dyadic International, Inc.
DYAI
Tempest Therapeutics, Inc.
TPST
MiNK Therapeutics, Inc.
INKT
Lumos Pharma, Inc.
LUMO
AN2 Therapeutics, Inc.
ANTX
Forte Biosciences, Inc.
FBRX
Kintara Therapeutics, Inc.
KTRA
Silo Pharma, Inc.
SILO
Protagenic Therapeutics, Inc.
PTIX
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%